| Dr Jennifer Wales, PHARMD | |
|
8302 Old Sauk Rd, Middleton, WI 53562-4404 | |
| (608) 512-9346 | |
| Not Available |
| Full Name | Dr Jennifer Wales |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 8302 Old Sauk Rd, Middleton, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164708145 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15102-40 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Wales, PHARMD 9020 Ancient Oak Ln, Verona, WI 53593-8455 Ph: () - | Dr Jennifer Wales, PHARMD 8302 Old Sauk Rd, Middleton, WI 53562-4404 Ph: (608) 512-9346 |
News Archive
The Alcon Independent Director Committee (the "IDC") today announced that RiskMetrics Group, Inc. and Glass Lewis & Co., two global leaders in risk management, corporate governance and proxy advisory services, have both recommended that Alcon minority shareholders vote against all five of Novartis AG's ("Novartis") designees to the Alcon board of directors. As previously announced, pursuant to the terms of agreements between Novartis and Nestlé SA entered into in 2008, Alcon shareholders will vote on the conditional election of Novartis' board designees at an extraordinary general meeting on August 16, 2010.
Researchers at the Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona (IBB-UAB), in collaboration with the biopharmaceutical company SOM Biotech, located in the Barcelona Science Park (PCB), have published, in Nature Communications, the results of a drug repositioning study in which they describe a powerful drug, SOM0226 (tolcapone) that could significantly improve the pharmacological treatment of familial transthyretin amyloidosis (ATTR).
Doctors at Duke University Hospital have developed a new collaborative model in cancer care that reduced the rates at which patients were sent to intensive care or readmitted to the hospital after discharge.
The master gene called SRC-3 (steroid receptor coactivator 3) not only enhances estrogen-dependent growth of cancer cells by activating and encouraging the transcription of a genetic message into a protein, it also sends a signal to the cell membrane to promote cell motility or movement - a key element of cancer spread or metastasis, said Baylor College of Medicine (www.bcm.edu) researchers and collaborators in a report that appears in the current issue of the journal Molecular Cell.
As people get older, the more likely they are to take several different medicines on a regular basis. However, this increases the risk of adverse effects, including interactions between the various active agents.
› Verified 5 days ago
Mrs. Carolyn L Starr, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2010 Branch St, Middleton, WI 53562 Phone: 608-831-6548 Fax: 608-831-4995 | |
Thomas John Gehin, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2010 Branch St, Middleton, WI 53562 Phone: 608-831-6548 | |
Daniel Joseph Duffy, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2010 Branch St, Middleton, WI 53562 Phone: 920-831-6548 | |
Jane Greischar, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6333 University Ave, Middleton, WI 53562 Phone: 608-310-5389 Fax: 608-285-9603 | |
Kathleen Taylor, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2150 Deming Way, Middleton, WI 53562 Phone: 608-824-3959 | |
Christine Van Haren, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2010 Branch St, Middleton, WI 53562 Phone: 608-831-6548 |